Seaport Therapeutics, Inc.
SPTX
$24.22
$0.512.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 273.31M | 182.61M | -- | ||
| Total Receivables | 4.86M | 3.28M | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 2.25M | 1.27M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 1.76M | 1.19M | -- | ||
| Total Current Assets | 282.18M | 188.34M | -- | ||
|
|
|||||
| Total Current Assets | 282.18M | 188.34M | -- | ||
| Net Property, Plant & Equipment | 5.10M | 5.45M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 454.00K | 3.84M | -- | ||
| Total Assets | 441.68M | 227.67M | -- | ||
|
|
|||||
| Total Accounts Payable | 5.71M | 4.79M | -- | ||
| Total Accrued Expenses | 8.36M | 7.83M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 1.61M | 1.60M | -- | ||
| Total Finance Division Other Current Liabilities | -- | 11.00K | -- | ||
| Total Other Current Liabilities | -- | 11.00K | -- | ||
| Total Current Liabilities | 15.67M | 14.22M | -- | ||
|
|
|||||
| Total Current Liabilities | 15.67M | 14.22M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 3.41M | 3.74M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 19.08M | 17.97M | -- | ||
|
|
|||||
| Common Stock & APIC | 625.19M | 23.83M | -- | ||
| Retained Earnings | -202.12M | -139.52M | -- | ||
| Treasury Stock & Other | -475.00K | 64.00K | -- | ||
| Total Common Equity | 422.60M | -115.62M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 325.33M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 325.33M | -- | ||
|
|
|||||
| Total Common Equity | 422.60M | -115.62M | -- | ||
| Total Preferred Equity | -- | 325.33M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 422.60M | 209.71M | -- | ||
|
|
|||||